Skip to main content
MMSI
NASDAQ Industrial Applications And Services

Merit Beats Q3, Raises 2026 EPS Guidance, Discloses $45M Solo Pace Buy

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$93.39
Mkt Cap
$5.576B
52W Low
$59.74
52W High
$94.85
52W Position info
56% above low
Off High info
1.5% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

MMSI sits 56% above its 52-week low of $59.74.

Summary

Merit reported Q3 revenue of $416.2 million (+8.4%) and non-GAAP EPS of $1.12 (+22%), raised 2026 EPS guidance, and disclosed a $45 million cash acquisition of Solo Pace that closed October 13, 2026.


Key Events · Earnings and Guidance · MMSI

  • Q3 Beat With 9% Organic Growth

    Revenue of $416.2 million rose 8.4%, while constant currency revenue, organic, climbed 8.9% to $412.5 million.

  • 2026 EPS Guidance Raised

    Full-year non-GAAP EPS guidance was lifted to $4.33-$4.37 (13%-14% growth) from $4.25-$4.35; revenue guidance now stands at $1.635-$1.642 billion.

  • Margins Expand Sharply

    GAAP operating margin came in at 14.1% versus 11.1% a year ago, and non-GAAP operating margin reached 21.3% versus 19.7%; non-GAAP EPS was $1.12, up 22%.

  • $45M Solo Pace Acquisition Closed

    On October 13, 2026, Merit paid approximately $45 million in cash for all remaining Solo Pace equity, adding TAVR temporary pacing technology; the deal is immaterial to 2026 results and slightly accretive to 2027 non-GAAP EPS.


Analysis · MMSI · Industrial Applications And Services

Merit beat its own expectations on both the top and bottom lines and lifted full-year non-GAAP EPS guidance to $4.33-$4.37 from $4.25-$4.35, with revenue now guided to $1.635-$1.642 billion. Operating leverage was on display: GAAP operating margin jumped to 14.1% from 11.1%, and non-GAAP EPS rose 22% to $1.12. Separately, the filing reveals a $45 million all-cash acquisition of Solo Pace (TAVR temporary pacing) that closed October 13, 2026 — a bolt-on management calls immaterial to 2026 results and slightly accretive to 2027 non-GAAP EPS. With the stock near its 52-week high, the raise and margin expansion support the current multiple; the main swing factors are tariff/trade policy and integration of a string of recent deals.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MMSI was trading at $93.39 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.6B. The 52-week trading range was $59.74 to $94.85. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MMSI - Latest Insights

MMSI
Oct 29, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $93.39
Real-time Price: $86.79 info
Change: -$6.60 (-7%) info
Market Cap: $5.2B info
MMSI
Oct 29, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $93.39
Real-time Price: $86.79 info
Change: -$6.60 (-7%) info
Market Cap: $5.2B info
MMSI
Jul 30, 2026, 4:36 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $87.03
Real-time Price: $86.79 info
Change: -$0.2428 (-0.28%) info
Market Cap: $5.2B info
MMSI
Jul 30, 2026, 4:30 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $83.35
Real-time Price: $86.79 info
Change: +$3.44 (+4%) info
Market Cap: $5.2B info
MMSI
May 19, 2026, 4:54 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $63.77
Real-time Price: $86.79 info
Change: +$23.02 (+36%) info
Market Cap: $5.2B info